RNTX
Rein Therapeutics Inc. · Healthcare
Voss Capital, LP bought $128K of Rein Therapeutics Inc.
10% owner
Bought$127,593
$1.22Price
104,183Shares
+8%Stake
What RNTX did for a copier
- $1,000 copied at Wed, Nov 19 open, $1.22
- $1,033
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Jan 5 close.
Voss Capital, LP's record
6 other buys with 3 months of prices since 2020: on average −20.9% against the S&P 500, and 1 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Nov 14. Filed Tue, Nov 18, 5:30 PM ET, after the close. Returns use the Nov 19 open and the Jan 5 close. Not investment advice.